FDA to Develop List of Bulk Drug Substances for Compounding Drug Products Under Section 503A of the FD&C Act

Summary

The FDA is preparing to create a list of bulk drug substances that can be used to manufacture compounding drug products, following a revised request for nominations from interested groups and individuals, in accordance with section 503A of the Federal Food, Drug, and Cosmetic Act